The launch of the first weight-loss drug pills in Australia is expected to trigger an explosion in the number of people taking the drugs, but at what cost?
When Kim Roberts collapsed on a Sydney street three years ago, it was a wake-up call for the 43-year-old who had no idea she had a genetic condition that put her at high risk of heart attacks.
Roberts, a busy mother of six with a full-time job, woke up in an ambulance demanding to be taken back to work, but her doctor had other ideas.
Gift articles to anyone you choose each month when you subscribe.
Compare how 4 other independent news outlets reported on this story.
A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.
In her new book “Reboot: AI and the Race to Save Democracy,” writer Beth Simone Noveck warns that while AI can increase efficiency, predictive models pose significant ethical and societal risks.
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Prescriptions for these beta blockers are soaring among England’s teenage girls. But they deserve more than this sticking-plaster approach, says Guardian columnist Rhiannon Lucy Cosslett
